Ryan Meineke, MD
Orthopaedic Surgery · Encinitas, CANPI 1851579015
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,770 of the $4,252 with a category attached, or 65.1%. Stryker accounts for 67.2% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $2,460 and has fallen 83.6% since, to $405 in 2025.
Across 62 payments — averaging $68.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Bioventus LLC$408
- Biotissue Holdings Inc.$307
- Medical Device Business Services, Inc.$115
- Pacira Pharmaceuticals Incorporated$114
- Zimmer Biomet$107
- plus $343 from 11 others
Across 6 payments — averaging $4445.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$27K
What the payments were for
- Travel & lodging$1,41633%
- Food & beverage$2,77065%
- Other$662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 21 | $2,859 |
| Bioventus LLC | 19 | $408 |
| Biotissue Holdings Inc. | 2 | $307 |
| Medical Device Business Services, Inc. | 1 | $115 |
| Pacira Pharmaceuticals Incorporated | 1 | $114 |
| Zimmer Biomet | 3 | $107 |
| Integra Lifesciences Corporation | 1 | $66 |
| Johnson & Johnson | 3 | $48 |
| Acumed LLC | 2 | $47 |
| Elevate Surgical Co | 2 | $34 |
| Paragon 28, Inc. | 1 | $32 |
| Smith+Nephew | 1 | $31 |
| Bausch & Lomb Americas Inc. | 1 | $25 |
| Vertex | 1 | $19 |
| Assertio Therapeutics, Inc. | 1 | $18 |
| Innovation Technologies Inc | 1 | $13 |
| Heron Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$1,124
- PROPHECY$1,009
- NEOX$247
- CLARIX$247
- FLEXBAND$164
- Foot and Ankle$159
- INFINITY ADAPTIS$134
- EXPAREL$114
How this compares
$4,252 in reported general payments places this provider in the 55th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $133 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $83 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Encinitas
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.